Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sygnature Discovery announced a new addition to its leadership team, with the appointment of industry veteran Jade Dagher as General Manager for Canada.
read more
Audax Private Equity has entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. The deal is expected to close in the fourth quarter and is subject to regulatory approvals.
read more
Wednesday, August 21, 2024
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has acquired ZenBio Inc., a provider of advanced cell products and services. Together, BioIVT and ZenBio will offer an expanded portfolio of ...
read more
Wednesday, August 21, 2024
SGS announced the introduction of new specialized bioanalytical testing services in the North American pharmaceutical and biopharmaceutical markets.
read more
Wednesday, August 21, 2024
Cardinal Health announced plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business.
read more
Wednesday, August 21, 2024
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics ...
read more
Wednesday, August 21, 2024
PCI Pharma Services has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.
read more
Thursday, August 29, 2024
Hyundai Bioscience Co., Ltd, currently pursuing Emergency Use Authorization (EUA) for its oral COVID-19 treatment, Xafty®, for mild-to-moderate cases, announced on August 27th that it has submitted an Investigational New Drug (IND) application for ...
read more
Thursday, August 29, 2024
Bora Pharmaceuticals Co., Ltd. announced a strategic investment into Tanvex Biopharma Co., Ltd., whereby Bora Biologics, a wholly owned subsidiary of Bora and specialist large molecule CDMO, and Tanvex will combine their biomanufacturing facilities ...
read more
AtkinsRéalis Group Inc. an engineering services and nuclear company has been chosen by Jubilant HollisterStier to provide detailed design for the expansion of their sterile injectable facility in Montreal as part of Canada's Biomanufacturing and Life...
read more
Tuesday, September 03, 2024
Rentschler Biopharma SE announced the launch of an expanded service offering at its dedicated advanced therapies site in Stevenage, UK. This enhancement introduces a new lentiviral vector manufacturing (LVV) toolbox, complementing the company’s ...
read more
Tuesday, September 03, 2024
Renaissance Lakewood announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.
read more
Tuesday, September 03, 2024
Enzene Biosciences announced the appointment of Norm Stoffregen as SVP, site head, and head of biologics manufacturing at the company’s new $50 million manufacturing facility in Hopewell, near Princeton, New Jersey.
read more
Tuesday, September 03, 2024
Simtra BioPharma Solutions announced the appointment of Dr. Mike Schaefers, Ph.D., as Chief Commercial Officer and Head of Business Development. In this role, Dr. Schaefers will oversee global commercial operations, driving business growth, enhancing...
read more
Thursday, September 05, 2024
CoreRx, Societal CDMO, and Bend Bioscience have announced their unification under the Bend Bioscience brand. This merger brings together three highly respected organizations, each with a unique legacy and distinct strengths, to form a comprehensive ...
read more